News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Lou Barbato, MD

Lou Barbato, MD

Dr Barbato is the chief medical officer of Incannex Healthcare.

Articles by Lou Barbato, MD

Lou Barbato

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

ByLeah Kuntz,Lou Barbato, MD

December 4th 2025

Latest Updated Articles

Trending on Psychiatric Times

Okie Tokie Talk: Adolescent Cannabis Use in Oklahoma, the Sooner State

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Data Presentation on XPro1595 for Alzheimer Disease With Inflammation at CTAD

Delay on Cobenfy Alzheimer Disease Psychosis Data Following Phase 3 Study “Irregularities,” New Patients Enrolled

Antidepressants Assessed for Reducing Negative Symptoms of Schizophrenia

© 2025 MJH Life Sciences^®

All rights reserved.